ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Incremental Benefit of Lipid Lowering in a Large Chinese Population Aged 75 Years and Older With Established Atherosclerotic Cardiovascular Disease

Lin, Zhongqiu; Chen, Yanmei; Xiao, Zhiwen; Xu, Wenlong; Chen, Guojun; Huang, Chixiong; Feng, Weijing; Xie, Zhiquan; Liao, Wangjun; Liao, Yulin; Bin, Jianping*; Feng, Li*; Wang, Shifei*南方医科大学; 中山大学
Mayo Clinic Proceedings2023-9DOI: 10.1016/j.mayocp.2023.06.003
1被引10阅读
引用收藏
分享

摘要

Objective: To explore the optimal low-density lipoprotein cholesterol (LDL-C) level in patients aged 75 years and older with established atherosclerotic cardiovascular disease (ASCVD).Patients and Methods: We conducted a retrospective multicenter cohort study of veterans aged 75 years and older with ASCVD who were regularly hospitalized or medically examined in 15 medical institutions in southern China from January 1, 2006, to December 31, 2013. Follow-up continued through October 1, 2021. The time-weighted average (TWA) LDL-C level represented the average LDL-C level during follow-up. Participants were divided into TWA LDL-C groups of 55.0 mg/dL or lower, 55.1 to 70.0 mg/dL, 70.1 to 85.0 mg/dL, 85.1 to 100.0 mg/dL, and greater than 100.0 mg/dL. The subgroup with LDL-C levels lower than 55.0 mg/dL was further subdivided into groups with LDL-C levels from 40.1 to 55.0 mg/dL and 40.0 mg/dL or less. The association of TWA LDL-C levels with outcomes was evaluated with Cox proportional hazards models.Results: Overall, 6387 patients aged 75 years or older with ASCVD were included (mean age, 79.4 years). In total, 4267 major adverse cardiovascular events, 1518 stroke events, and 515 myocardial infarction events occurred during a mean follow-up of 12.7 years. Generally, lower TWA LDL-C level was associated with a lower risk of cardiovascular events but was not associated with a higher risk of adverse events in elderly individuals with ASCVD, with the lowest cardiovascular risk observed for LDL-C levels of less than 55.0 mg/dL. After multivariable adjustment, the risk of a major adverse cardiovascular event was 1.30 (95% CI, 1.26 to 1.34; P<.001) for a per SD increment in TWA LDL-C level. Compared with TWA LDL-C levels of 40.1 to 55.0 mg/dL, TWA LDL-C levels of 40.0 mg/dL or less were associated with an increased risk of hemorrhagic stroke (hazard ratio, 3.71; 95% CI, 1.89 to 7.26).Conclusion: Low-density lipoprotein cholesterol levels from 40.1 to 55.0 mg/dL exhibited the maximum cardiovascular benefit in patients aged 75 years and older who had ASCVD. Lowering LDL-C levels to 40.0 mg/dL or less might increase the risk of hemorrhagic stroke.

学科与关键词

关键词
ACUTE CORONARY SYNDROMESSECONDARY PREVENTIONLDL CHOLESTEROLISCHEMIC-STROKESTATIN THERAPYMETAANALYSISMORTALITYEFFICACYSAFETYRISK
相关
加载中…
  • Cumulative remnant cholesterol predicts cardiovascular outcomes in elderly patients with atherosclerotic cardiovascular disease
    Xiao, Zhiwen; Lin, Zhongqiu; Xu, Lin; Xu, Wenlong; Huang, Haoxiang; Wang, Yuegang; Cao, Shiping; Xie, Zhiquan; Liao, Wangjun; Liao, Yulin; Bin, Jianping*; Feng, Weijing*; Chen, Yanmei*European Journal of Preventive Cardiology, 2023, 30(17): 1924-1934.被引 3
  • Post-treatment level of LDL cholesterol and all-cause mortality in patients with atherosclerotic cardiovascular disease: evidence from real-world setting
    Luo, Fan; Lin, Yuxin; Zhang, Xiaodong; Li, Yanqin; Su, Licong; Zhou, Shiyu; Xu, Ruqi; Gao, Qi; Chen, Ruixuan; Guo, Zhixin; Nie, Sheng*; Xu, Xin*European Journal of Preventive Cardiology, 2024, 31(3): 337-345.
  • Association of Low-Density Lipoprotein Cholesterol Levels with More than 20-Year Risk of Cardiovascular and All-Cause Mortality in the General Population
    Rong, Shuang*; Li, Benchao; Chen, Liangkai; Sun, Yangbo; Du, Yang; Liu, Buyun; Robinson, Jennifer G.; Bao, Wei*Journal of the American Heart Association, 2022, 11(15): e023690.被引 21
查看全部 →

发表信息

论文状态
公开发表
期刊
Mayo Clinic Proceedings
发表日期
2023-09
卷期
第 98 卷, 第 9 期
页码
1280-1296
DOI
10.1016/j.mayocp.2023.06.003
语言
ENGLISH
成果收录
SCIE
资助标注
National Natural Science Foundation of China [81771857, 82070315, 82200517]; Science and Technology Projects in Guangzhou [SL2022A04J01925]; Foundation of General Hospital of Southern Theater Command [82200517, 2021NZC028]

作者

  • L

    Lin, Zhongqiu (第一作者)

    southern med univ

  • C

    Chen, Yanmei

    southern med univ

查看全部 13 位作者收起作者
  • X

    Xiao, Zhiwen

    southern med univ

  • X

    Xu, Wenlong

    southern med univ

  • C

    Chen, Guojun

    southern med univ

  • H

    Huang, Chixiong

    southern med univ

  • F

    Feng, Weijing

    southern med univ

  • X

    Xie, Zhiquan

  • L

    Liao, Wangjun

    southern med univ

  • L

    Liao, Yulin

    southern med univ

  • B

    Bin, Jianping (通讯)

    southern med univ

  • F

    Feng, Li (通讯)

    2 · sun yat sen univ · zhongshan peoples hosp

  • W

    Wang, Shifei (通讯)

    southern med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417